D61.82 - Myelophthisis
- Applicable to Myelophthisis
- The 2025 edition of ICD10-CM D61.82 became effective on October 1, 2024.
- This is the American ICD10-CM version of D61.82 - other international versions of ICD10 D61.82 may differ.
- D61.82 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Leukoerythroblastic anemia
- Myelophthisic anemia
- Panmyelophthisis
Type 1 Excludes
- idiopathic myelofibrosis (D47.1)
- myelofibrosis NOS (D75.81)
- myelofibrosis with myeloid metaplasia (D47.4)
- primary myelofibrosis (D47.1)
- secondary myelofibrosis (D75.81)
codeAlso
- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
- tuberculosis (A15.-)
Billable/Specific Code
The following codes above D61.82 contain annotation back-references that may be applicable to D61.82:
- Chapter: D50-D89 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Section: D60-D64 - Aplastic and other anemias and other bone marrow failure syndromes
- Category: D61 - Other aplastic anemias and other bone marrow failure syndromes
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com